Stock screenerAll disclosures →
EDGAR →
TKNO
Conviction 88HealthcareScan · Mon, Aug 10, 2026Bullish engulfing
TKNO$6.72+3.95%
ResistanceSupportVol 14Vol MA14 192.1K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price6.72
Change+3.95%
Gap-0.77%
Rel volume7.87×
Avg volume167.29K
Avg $ vol986.07K
SMA 205.43
SMA 505.25
SMA 2004.00
Price vs 50+27.89%
Price vs 200+67.82%
MA stackbullish
50/200 cross—
Supertrendup · 5.22
RSI (14)74
MACD hist0.16
MACD crossbull · 3d
Stoch %K / %D91 / 92
ADX (14)31
+DI / −DI34 / 9
RSI divergence—
MACD divergence—
ATR %+6.83%
ADR %7.85%
52w high6.72
52w low1.99
From 52w high+0.00%
Above 52w low+237.44%
New 52w highYes
SqueezeOff
Bollinger width38.07%
%B1.12
Donchian pos91.06%
Donchian high6.91
Donchian low4.73
AVWAP (52w high)6.67
vs AVWAP high+0.65%
AVWAP (52w low)4.11
vs AVWAP low+63.35%
OBV trendUp
Chaikin MF (20)0.17
Today vs 20d7.87×
Avg vol (14d)192.09K
Avg vol (20d)167.29K
Avg $ vol (20d)986.07K
Market cap360.52M
RS 3m (vs SPY)+55.80%
RS 6m (vs SPY)+166.76%
RS line new highNo
Trend template5/8
Technical rank96.2
1 week+26.70%
1 month+25.28%
3 months+75.33%
6 months+198.44%
1 year+54.72%
YTD+72.18%
P/E-20.89
P/B5.76
P/S8.90
P/FCF-36.81
EPS-0.3200
Div yield—
ROE-27.57%
ROA-18.00%
Debt/Eq0.17
Current4.49
EV/EBITDA-34.36
Gross margin33.17%
Net margin-42.59%
Rev growth7.35%
EPS growth35.47%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value365.37M
Revenue12.19M
Net income-3.17M
Gross profit4.88M
Free cash flow-9.79M
IndustryIN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
ExchangeNasdaq
Shares out53.61M
Employees158
ListedFri, Jun 25, 2021
Free float8.47M
Float %15.8%
Short interest1.58M
Days to cover9.7d
Short volume52.6%
Squeeze score86 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.06 vs −$0.08
Last surprise+25.0% beat
Setup gradeA+
Conviction88 / 100
Pattern quality—
Tech rank96.2 / 100
Group rank86 / 100 · Leading
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmBullish engulfing
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in TKNO
No recent disclosed trades by Congress in TKNO. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in TKNO · 4 buys · 1 sell
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
DEMSKI MARTHA J Director · Common Stock · 2026-07-14 | Dispose | 12K | — | 2026-07-14 | 2026-07-16 |
DEMSKI MARTHA J Director · Common Stock · 2026-07-14 | Acquire | 12K | — | 2026-07-14 | 2026-07-16 |
ROBERTSON BRETT Director · Non-Qualified Stock Option (right to buy) · 2026-06-01 | Grant | 55K | $0 | 2026-06-01 | 2026-06-02 |
DEMSKI MARTHA J Director · Non-Qualified Stock Option (right to buy) · 2026-06-01 | Grant | 55K | $0 | 2026-06-01 | 2026-06-02 |
Vos Alexander Director · Non-Qualified Stock Option (right to buy) · 2026-06-01 | Grant | 55K | $0 | 2026-06-01 | 2026-06-02 |
SEC filings
EDGAR filings in TKNO · 3 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.